Warburg Pincus and Mubadala Acquire Pharma Intelligence from Informa
June 1, 2022
Warburg Pincus, joined by Mubadala Investment Company, completed the acquisition of Pharma Intelligence (the Citeline suite and related specialist brands) from Informa PLC, with Informa retaining a 15% equity stake. The investors said they will invest in product development and innovation to expand Pharma Intelligence's position in the pharmaceutical data and analytics market; Jay Nadler was appointed Executive Chair following completion.
- Buyers
- Warburg Pincus, Mubadala Investment Company
- Targets
- Pharma Intelligence
- Sellers
- Informa PLC
- Industry
- Data & Analytics
- Location
- England, United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Warburg Pincus Invests in Infoniqa
September 5, 2020
Software
Funds advised by Warburg Pincus LLC agreed to invest in Infoniqa, a leading DACH HR software and payroll services provider, alongside existing investor Elvaston and Infoniqa management. The investment is positioned as a strategic partnership to support Infoniqa's future growth and scale its SaaS payroll, outsourcing and HR solutions across the DACH region.
-
Montagu Acquires Maritime Intelligence (Lloyd's List Intelligence) from Informa Plc
August 4, 2022
Data & Analytics
Montagu, a UK-based private equity firm, has agreed to acquire Maritime Intelligence (commonly known as Lloyd's List Intelligence) from Informa Plc. The business provides maritime data, analytics, insight services and publishing (including Lloyd's List) and will join Montagu's portfolio to accelerate growth and expand its data & analytics capabilities.
-
Warburg Pincus Invests $100M in Miami International Holdings
August 22, 2024
Financial Services
Warburg Pincus has committed a $100 million growth investment in Miami International Holdings (MIH) to accelerate MIAX’s global expansion, fund construction of a physical trading floor for MIAX Sapphire in Miami, and support development of trading, matching-engine and clearing technology across MIH’s exchanges. The investment, which may be expanded subject to conditions, includes Warburg Pincus board participation and will also fund MIH’s further product development and potential acquisitions internationally.
-
Norstella and Citeline Merge to Create $5B Global Pharma Technology Company
June 28, 2022
Data & Analytics
Norstella (the group of Evaluate, MMIT, Panalgo and The Dedham Group) announced an agreement to merge with Citeline (formerly Pharma Intelligence) to form a combined global pharmaceutical technology and intelligence business valued at about $5 billion. The combination brings clinical trial intelligence, commercial data and real‑world analytics together to offer an end‑to‑end suite of solutions for life sciences companies; the deal involves financial sponsors including Hg (Norstella) and Warburg Pincus (Citeline).
-
Warburg Pincus and Vista Equity Partners Invest in Infoblox
September 8, 2020
Cybersecurity
Warburg Pincus has made a significant growth investment in Infoblox, joining existing investor Vista Equity Partners as equal partners. The investment will accelerate development and adoption of Infoblox's DDI products and its cloud-native BloxOne platform to expand cloud-managed networking and security services.
-
Kohlberg & Mubadala Acquire Majority Stake in PCI Pharma Services
December 1, 2020
Healthcare Services
Private equity firm Kohlberg & Company acquired a majority stake in PCI Pharma Services, with Mubadala Investment Company joining as a significant investor and Partners Group retaining a minority stake. The deal (signed August 24, 2020 and closed December 1, 2020) positions PCI to expand capabilities—such as sterile fill/finish and high-potency manufacturing—and further geographic reach while continuing to serve pharmaceutical and biopharmaceutical customers from its Philadelphia headquarters.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.